000538 云南白药
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额713,5984,297,0033,502,7423,209,4105,223,278
投资活动产生之现金流量净额(66,638)(1,199,001)518,581(6,316,083)3,998,696
筹资活动产生之现金流量净额(471,209)(6,977,735)(2,918,042)(2,733,304)(4,622,683)
汇率变动对现金及现金等价物的影响1,0323,4972,32516,272(7,154)
现金及现金等价物净增加/(减少)176,782(3,876,236)1,105,605(5,823,705)4,592,138
期初现金及现金等价物余额10,275,53014,151,76513,046,16018,869,86514,277,727
期末现金及现金等价物余额10,452,31210,275,53014,151,76513,046,16018,869,865